Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1504PDF: 856HTML: 964figures: 154table 1: 163table2: 161table3: 162 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
807PDF: 477HTML: 1284 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3671PDF: 1417HTML: 460Figures . Eliassian: 203 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
890PDF: 558HTML: 2178Cover Letter: 175 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
934PDF: 518HTML: 711 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3755Suppl. Files: 1048PDF: 1021Html: 107 -
IMMUNOLOGY OF TUBERCULOSIS
5121PDF: 1959HTML: 7250Untitled: 186 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1323PDF: 1270HTML: 79 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1859PDF: 1126HTML: 249 -
-
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
2953PDF: 995HTML: 3059 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1116PDF: 802HTML: 2164Figue 1: 158 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3623PDF: 1207HTML: 3863Untitled: 190Untitled: 241 -
-
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1692PDF: 502HTML: 16958Figure 4: 144Figure 3: 125Figure 2: 124Figure 1: 154 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3209PDF: 1309HTML: 2609 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4708PDF: 1708HTML: 2686Untitled: 191 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3218PDF: 1273HTML: 6172 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1086PDF: 876HTML: 281 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1246PDF: 981HTML: 108 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3167PDF: 1191HTML: 8082 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1538PDF: 769HTML: 840jdoe, table 2 infections CML .doc: 174jdoe, table 1 infections CML .doc: 161 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4001PDF: 1534HTML: 840 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1737PDF: 1019HTML: 215 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1337PDF: 797HTML: 3103







